Cintia Piccina
U.S. CCO & Country Gen Manager · Autolus Therapeutics plc
IndividualSelling only
- 2026
- Sep 3, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Cintia Piccina's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Bain Capital Life Sciences Investors, LLC - $115.00M in HTFL purchases and sales in the last 12 months
- Michael Simanovsky - $110.65M in SNDA purchases and sales in the last 12 months
- Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
- TCO GROUP HOLDINGS, L.P. - $106.38M in INNV purchases and sales in the last 12 months
- IGNITE AGGREGATOR LP - $106.38M in INNV purchases and sales in the last 12 months
- Bruce Booth - $100.59M in KYMR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Cintia Piccina?
Cintia Piccina is a corporate insider, tracked as U.S. CCO & Country Gen Manager of Autolus Therapeutics plc (AUTL). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Cintia Piccina submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Cintia Piccina been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($16K) across all tracked filings.
